The Company
Atlas Antibodies was founded in 2006 by researchers at the Royal Institute of Technology (KTH)
in Stockholm and the Rudbeck Laboratory, Uppsala University in Uppsala, Sweden.
Atlas Antibodies will handle the production, marketing and sales of the antibody
products developed and validated in the Human Proteome Resource (HPR) Center.
The Human Proteome Resource (HPR) Center is performing a systematic exploration of the human proteome with Affinity (Antibody) based Proteomics, combining high-throughput generation of affinity-purified (mono-specific) antibodies with protein profiling using tissue microarrays. The Human Proteome Resource (HPR) Center is located in Stockholm and Uppsala, Sweden and is running the Swedish Human Protein Atlas (HPA) program funded by the Knut and Alice Wallenberg Foundation. The HPA program generates expression and localization patterns of proteins in a large portion of both normal and cancer human tissues and organs resulting in the antibody-based profiling presented in the publicly available Human Protein Atlas (HPA) (www.proteinatlas.org). The HPA vision is to enable the systematic generation of quality assured antibodies to all non-redundant human proteins and to use these reagents to functionally explore human proteins, protein variants and protein interactions.
The Main Office and the research laboratory are located in Stockholm, Sweden. Atlas Antibodies distributes products worldwide.
The Human Proteome Resource (HPR) Center is performing a systematic exploration of the human proteome with Affinity (Antibody) based Proteomics, combining high-throughput generation of affinity-purified (mono-specific) antibodies with protein profiling using tissue microarrays. The Human Proteome Resource (HPR) Center is located in Stockholm and Uppsala, Sweden and is running the Swedish Human Protein Atlas (HPA) program funded by the Knut and Alice Wallenberg Foundation. The HPA program generates expression and localization patterns of proteins in a large portion of both normal and cancer human tissues and organs resulting in the antibody-based profiling presented in the publicly available Human Protein Atlas (HPA) (www.proteinatlas.org). The HPA vision is to enable the systematic generation of quality assured antibodies to all non-redundant human proteins and to use these reagents to functionally explore human proteins, protein variants and protein interactions.
The Main Office and the research laboratory are located in Stockholm, Sweden. Atlas Antibodies distributes products worldwide.